Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate-Reference-Cited by-同舟云学术

Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate

Published:2007-06-28 Issue:4 Volume:3 Page:413-426
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Dunn Warwick B.,Broadhurst David I.,Deepak Sasalu M.,Buch Mamta H.,McDowell Garry,Spasic Irena,Ellis David I.,Brooks Nicholas,Kell Douglas B.,Neyses Ludwig

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s11306-007-0063-5.pdf

Reference71 articles.

1. Amuro, Y., Nakaoka, H., Shimomura, S., Fujikura, M., Yamamoto, T., Tamura, S., Hada, T., Higashino, K. (1988) Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clin. Chim. Acta, 178, 151–158

2. Anker, S.D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C.H., Cicoira, M., Shamim, W., Kemp, M., Segal, R., Osterziel, K.J., Leyva, F., Hetzer, R., Ponikowski, P., Coats, A.J. (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation, 107, 1991–1997

3. Bland, J.M., Altman, D.G. (1995) Multiple significance tests: the Bonferroni method. BMJ, 310, 170

4. Bongartz, L.G., Cramer, M.J., Doevendans, P.A., Joles, J.A., Braam, B. (2005) The severe cardiorenal syndrome: ‘Guyton revisited’. Eur. Heart. J., 26, 11–7

5. Broadhurst, D., Kell, D.B. (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics, 2, 171–196; DOI: 10.1007/s11306-006-0037-z

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients;Heliyon;2024-09

2. Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection Fraction;2024-07-25

3. Genetic drivers of human plasma metabolites that determine mortality in heart failure patients with reduced ejection fraction;Frontiers in Cardiovascular Medicine;2024-07-09

4. Serum metabolomics improves risk stratification for incident heart failure;European Journal of Heart Failure;2024-04

5. Epitranscriptomic regulations in the heart;Physiological Research;2024-03-22